GLAND PHARMA
Back to Income Statement
|
GLAND PHARMA Last 5 Year Profit After Tax History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹699 Cr | ₹772 Cr | ₹781 Cr | ₹1,212 Cr | ₹997 Cr |
What is the latest Profit After Tax of GLAND PHARMA ?
| Year | Profit After Tax |
|---|---|
| Mar2026 | ₹699 Cr |
| Mar2025 | ₹772 Cr |
| Mar2024 | ₹781 Cr |
| Mar2023 | ₹1,212 Cr |
| Mar2022 | ₹997 Cr |
How is Profit After Tax of GLAND PHARMA Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹699 Cr | -9.57 | |
| Mar2025 | ₹772 Cr | -1.10 | |
| Mar2024 | ₹781 Cr | -35.54 | |
| Mar2023 | ₹1,212 Cr | 21.54 | |
| Mar2022 | ₹997 Cr | - | |
Compare Profit After Tax of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹48,128.9 Cr | 3.1% | 3.4% | 45.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,437.0 Cr | -0.5% | -3% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,054.0 Cr | 1.6% | 9.3% | 54.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,842.0 Cr | 3.5% | 2.3% | 40.6% | Stock Analytics | |
| CIPLA | ₹111,565.0 Cr | 1.6% | -3.2% | -11.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,163.0 Cr | 5.8% | 3.2% | -8.3% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 3.1% |
3.4% |
45.5% |
| SENSEX | 0.7% |
-3.9% |
-8.9% |
You may also like the below Video Courses